Home
Stocks
Hindustan Bio Sciences Ltd

Hindustan Bio Sciences Ltd share Price Today

BSE

Apr 19, 2024 04:00 PM

Hindustan Bio Sciences Ltd

SECTOR : Trading | BSE :532041 |

1D
1W
1M
3M
1Y
5Y
MAX

BUY SELL SEP

Company details

Day Low

Day High

8.00

8.49

52W Low

52W High

5.15

15.18

6M Return -35.25%

1Y Return -3.23%

Mkt Cap.(Cr) 8.30

Volume 6,584

Div Yield 0.00%

OI

-

OI Chg %

-

Volume 6,584

SWOT Analysis
Financials
Comparison
Information
FAQs

Hindustan Bio Sciences Ltd: 8.10
0.00 (0.00 %)

BSE

Hindustan Bio Sciences Ltd shares SWOT Analysis

Strengths (12)

Rising Net Cash Flow and Cash from Operating activity
Company with high TTM EPS Growth
Effectively using its capital to generate profit - RoCE improving in last 2 years

Weakness (4)

Companies with High Debt
Companies with Increasing Debt
Low Piotroski Score : Companies with weak financials

Opportunity (0)

Data not found

Threats (2)

High PE (PE > 40)
Increasing Trend in Non-Core Income

Resistance and support

R1 8.4

R2 8.7

R3 8.9

Pivot

8.20

S1 7.9

S2 7.7

S3 7.4

EMA SMA

20 Day

7.9

50 Day

8.2

100 Day

8.4

200 Day

8.1

20 Day

7.7

50 Day

8.3

100 Day

8.8

200 Day

8.2

Delivery and volume

Discover More

CLIENT NAME	DEAL TYPE	ACTION	DATE	AVG. PRICE	QUANTITY	EXCHANGE
MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Bulk	Purchase	2023-10-20	13.78	65000	BSE
JAI VINAYAK SECURITIES	Bulk	Purchase	2023-10-18	12.48	53680	BSE
JAI VINAYAK SECURITIES	Bulk	Sell	2023-10-18	12.37	53680	BSE

Discover More

Public 87.82%
Promoter 12.19%
Other Institutions 0%

Name	Category	Shares
VENKATA RAMA MOHAN RAJU JAMPANA	PROMOTER	9.39%
SUPER SOLUTIONS INDIA PRIVATE LIMITED	PROMOTER	2.78%

FINANCIALS

Sales

Operating Profit

Profit after Tax

DISCOVER MORE

Equity

Reserves and Surplus

Debt

DISCOVER MORE

Sales

Operating Profit

Profit after Tax

DISCOVER MORE

PE

Debt/Equity

P BV

DISCOVER MORE

Hindustan Bio Sciences Ltd Stocks COMPARISON

Financials( ₹ in Cr)	Hindustan Bio Sciences Ltd	Adani Enterprises Ltd	Cello World Ltd	Aegis Logistics Ltd	Redington Ltd
Price	8.10	3,026.95	852.85	494.55	218.95
% Change	0	0.25	-0.45	-1.87	-1.13
Mcap ₹ Cr	8.30	345,072.60	18,100.12	17,358.71	17,115.65
Revenue TTM ₹ Cr	0.92	69,420.18	1,796.70	8,627.21	79,376.78
Net Profit TTM ₹ Cr	-0.04	475.37	285.07	510.70	1,439.39
PE TTM	405.00	90.96	68.46	34.51	14.36
1 Year Return	-3.23	63.53	7.72	28.04	27.00
ROCE	0.00	6.57	45.20	17.08	25.43
ROE	0.00	2.41	134.44	17.88	22.65

DISCOVER MORE

INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 0.75 Cr FV: 2.00

Period	MF Net Purchase / (sold)	FII Net
LAST 1M	26,468.76	-11,822.98
LAST 3M	81,914.65	34,986.47
LAST 6M	142,142.07	66,572.41
LAST 12M	217,201.91	193,346.69

ANNOUNCEMENT
CORPORATE ACTION

No Data Found

Date	Action Type	Ratio
No data found

DISCOVER MORE

Hindustan Bio Sciences Ltd Information

Stock PE (TTM)
405

Promoter Holding
12.19%

Book Value
0.6737

ROCE
0%

ROE
0%

Description

Hindustan Bio Science Ltd (Formerly known Hindustan Softel Ltd) was incorporated as Public Limited Company on December 16, 1991. The Company engaged in the manufacturing and sale of pharmaceutical products is an integrated firm with diversified operations in pharmaceutical and biotechnology sectors. The Company initially commenced operations in 1992 by sourcing bulk drugs (APIs) and drug intermediates for the Industry with a wellspring of global suppliers and associates. Previously, it was engaged in cement manufacturing and due to sluggish in the industry the company diversified its business into Bio Technology & Pharmaceuticals activities and the name of the Company was changed from Garuda Cements to Hindustan Bio-Sciences Ltd. In 2001, it diversified into software field and subsequently changed its name to Hindustan Softel Limited which presently got changed into Hindustan Bio Sciences Ltd. The Company acquired the shares of Venkar Chemicals Ltd in 2004 and consequently upon acquisition, it became Wholly owned subsidiary of the Company with effect from 19.08.2004. During 2006-07, Company got approval from Drugs Controller General of India (DCGI) and started marketing the nephrology product `Recombinant Human Erythropoietin` with the brand name `EPOVIN` from June, 2007. The Company to its credit has world class manufacturing facilities for dry and liquid injectables, liquid/dry syrups, Eye/Ear/Nasal drops, pre-filled syringes and non sterile/sterile ointments, tablets and capsules approved by several regulatory authorities and is trusted by healthcare professionals and patients across the globe. Presently, it is now manufacturing and marketing finished dosage forms of pharmaceutical products.

Hindustan Bio Science Ltd (Formerly known Hindustan Softel Ltd) was incorporated as Public Limited Company on December 16, 1991. The Company engaged in the manufacturing and sale of pharmaceutical products is an integrated firm with diversified operations in pharmaceutical and biotechnology sectors. The Company initially commenced operations in 1992 by sourcing bulk drugs (APIs) and drug intermediates for the Industry with a wellspring of global suppliers and associates. Previously, it was engaged in cement manufacturing and due to sluggish in the industry the company diversified its business into Bio Technology & Pharmaceuticals activities and the name of the Company was changed from Garuda Cements to Hindustan Bio-Sciences Ltd. In 2001, it diversified into software field and subsequently changed its name to Hindustan Softel Limited which presently got changed into Hindustan Bio Sciences Ltd. The Company acquired the shares of Venkar Chemicals Ltd in 2004 and consequently upon acquisition, it became Wholly owned subsidiary of the Company with effect from 19.08.2004. During 2006-07, Company got approval from Drugs Controller General of India (DCGI) and started marketing the nephrology product `Recombinant Human Erythropoietin` with the brand name `EPOVIN` from June, 2007. The Company to its credit has world class manufacturing facilities for dry and liquid injectables, liquid/dry syrups, Eye/Ear/Nasal drops, pre-filled syringes and non sterile/sterile ointments, tablets and capsules approved by several regulatory authorities and is trusted by healthcare professionals and patients across the globe. Presently, it is now manufacturing and marketing finished dosage forms of pharmaceutical products.

Hindustan Bio Sciences share price as on 19 Apr 2024 is Rs. 8.1. Over the past 6 months, the Hindustan Bio Sciences share price has decreased by 35.25% and in the last one year, it has decreased by 3.23%. The 52-week low for Hindustan Bio Sciences share price was Rs. 5.15 and 52-week high was Rs. 15.18.

Registered Address

H No 8-2-269/S PlotNo 31 RdNo2, Sagar Co-Op Hous Banjara Hills, Hyderabad, Telangana, 500034

Tel	:	91-40-23555161/23555181
Email	:	mohan.hindustanbio:gmail.com, pharma.hindustanbio:
Website	:	http://www.hindustanbiosciences.in

Registrar

Venture Capital & Corp. Inv.

AGM Date (Month)	:	Jul
Face Value Equity Shares	:	2
Market Lot Equity Shares	:	1
BSE Code	:	532041
NSE Code	:
Book Closure Date (Month)	:
BSE Group	:	XT
ISIN	:	INE597C01021

FAQ’s on Hindustan Bio Sciences Ltd Shares

How can I buy Hindustan Bio Sciences Ltd share?

You can buy Hindustan Bio Sciences Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Hindustan Bio Sciences Ltd Share.

What is the share price of Hindustan Bio Sciences Ltd?

Company share prices and volatile and keep changing according to the market conditions. As of Apr 19, 2024 04:00 PM the closing price of Hindustan Bio Sciences Ltd was ₹ 8.10.

What is the market cap of Hindustan Bio Sciences Ltd ?

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Apr 19, 2024 04:00 PM, the market cap of Hindustan Bio Sciences Ltd stood at ₹ 8.30.